MARK D. VINCENT

Corporate Board Profile

Tech Score: 0/100

← Back to All Directors

Aptose Biosciences Inc.

Filing Date Source Excerpt
2024-07-17 Named Executive Officers and Directors Mark D. Vincent 32,994 Shares beneficially owned Does not exceed one percent of Shares outstanding
2024-12-30 Name of Beneficial Owner Named Executive Officers and Directors Mark D. Vincent 35,695 *

Data sourced from SEC filings. Last updated: 2026-02-03